Clinical Trial Update: Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease [Phase 3]

View source ↗

Summary

Phase 3 trial of combination therapy with 5-fluorouracil and photodynamic therapy in post-transplant premalignant skin disease was terminated; results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Photodynamic Therapy

Snippet

Sponsor: The Cleveland Clinic | Conditions: Actinic Keratosis, Organ or Tissue Transplant; Complications | Phase 3 | Status: TERMINATED | Results posted: 2018-08-14